Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Teva Pharmaceutical Industries Ltd (NY: TEVA)
21.43 USD  +0.16 (+0.75%)
Official Closing Price  /  Updated: 5:56 PM EDT, Oct 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 4,090,600
Open 21.37
Bid (Size) 21.35 (2)
Ask (Size) 21.52 (10)
Prev. Close 21.27
Today's Range 21.31 - 21.77
52wk Range 10.85 - 25.96
Shares Outstanding 1,018,482,488
Dividend Yield 5.55%
Performance
YTD
+12.14%
+12.14%
1 Month
-13.03%
-13.03%
3 Month
-6.54%
-6.54%
6 Month
+20.26%
+20.26%
1 Year
+43.54%
+43.54%
Top News
More News
New Research: Key Drivers of Growth for Teva Pharmaceutical Industries, Axovant Sciences, SolarEdge Technologies, NantHealth, Kosmos Energy, and Retrophin — Factors of Influence, Major Initiatives and
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Teva Pharmaceutical... Read More
from GlobeNewswire News Releases
Stocks To Watch: Teva Pharmaceutical Sees RS Rating Rise To 84
A Relative Strength Rating upgrade for Teva Pharmaceutical shows improving technical performance. Read More
from Investor's Business Daily
More News
Read More
Regeneron's Drug Will Be Fifth In Asthma — But 'It Will Be The Best'
from Investor's Business Daily
Regeneron's Drug Will Be Fifth In Asthma — But 'It Will Be The Best'
from Investor's Business Daily
Noteworthy ETF Inflows: SPDW, PKX, TEVA, FLEX
category ETFs
from ETF Channel
Teva Pharmaceutical Clears Key Benchmark, Hitting 80-Plus RS Rating
from Investor's Business Daily
Borrowing costs could rise for indebted US blue chip companies
category companyNews
from Reuters: Company News
UPDATE 1-Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva
category companyNews
from Reuters: Company News
Stocks making the biggest move premarket: NFLX, IBM, CSX, UAL, TEVA & more
category Netflix Inc , United Continental Holdings Inc , Investing/Stock Market , and 16 more.
from CNBC.com News
Celltrion and Teva Announce FDA Oncologic Drugs Advisory Committee Recommends Approval of Celltrion BLA for CT-P10, a Proposed Rituximab Biosimilar
from Business Wire News Releases
UPDATE 1-U.S. appeals court upholds ruling that canceled Teva Copaxone patents
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X